Iridex (IRIX) Capital Expenditures Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 6.71% |
| Sep 27, 2025 | 10.20% |
| Jun 28, 2025 | 3.40% |
| Mar 29, 2025 | -30.53% |
| Dec 28, 2024 | 24.57% |
| Sep 28, 2024 | -41.01% |
| Mar 30, 2024 | -46.27% |
| Dec 30, 2023 | -21.55% |
| Sep 30, 2023 | 36.98% |
| Jul 1, 2023 | -30.69% |
| Apr 1, 2023 | -30.95% |
| Dec 31, 2022 | 20.26% |
| Oct 1, 2022 | -11.67% |
| Jul 2, 2022 | 4.78% |
| Apr 2, 2022 | -40.24% |
| Jan 1, 2022 | -14.14% |
| Apr 3, 2021 | -3.89% |
| Mar 28, 2020 | -29.73% |
| Sep 28, 2019 | -35.76% |
| Jun 29, 2019 | -28.53% |
| Mar 30, 2019 | -9.11% |
| Dec 29, 2018 | -19.51% |
| Sep 29, 2018 | -36.37% |
| Jun 30, 2018 | 13.12% |
| Mar 31, 2018 | 72.38% |
| Dec 30, 2017 | -17.04% |
| Sep 30, 2017 | -4.86% |
| Jul 1, 2017 | 12.38% |
| Apr 1, 2017 | 23.03% |
| Dec 31, 2016 | 33.78% |
| Oct 1, 2016 | 32.52% |
| Apr 2, 2016 | 19.84% |